RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.

Regulatory Focus™ > News Articles > Regulatory Update: Pending and New Guidance

Regulatory Update: Pending and New Guidance

Posted 01 March 2009 | By

This draft guidance provides information on the development of animal efficacy models under the "Animal Rule" (21 CFR 314.600 for drugs; 21 CFR 601.90 for biologics). The Animal Rule is the means by which FDA marketing approval may be granted based on animal efficacy data when human efficacy testing is neither ethical nor feasible.

Regulatory Focus newsletters

All the biggest regulatory news and happenings.

Subscribe

Regulatory Focus™ is doing essential, non-biased journalism during this unprecedented time. We appreciate your support as we bring you the news and intelligence you need to make an impact on global healthcare.

Regulatory Focus™ provides the intelligence you need to impact global healthcare during this crisis. Thank you for your support.